Vincent R. Anicetti's most recent trade in Coherus Biosciences Inc was a trade of 150,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 6, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2021 | 50,000 | 124,790 (0%) | 0% | 0 | Common Stock | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 20,000 | 73,402 (0%) | 0% | 0 | Common Stock | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.30 per share. | 05 Mar 2021 | 20,312 | 80,051 (0%) | 0% | 9.3 | 188,902 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.46 per share. | 05 Mar 2021 | 20,312 | 59,739 (0%) | 0% | 15.5 | 314,095 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 20,312 | 4,688 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.46 per share. | 05 Mar 2021 | 6,337 | 53,402 (0%) | 0% | 15.5 | 97,970 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 2,488 | 0 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.45 per share. | 17 Feb 2021 | 2,488 | 59,739 (0%) | 0% | 17.5 | 43,418 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 17 Feb 2021 | 2,488 | 62,227 (0%) | 0% | 2.5 | 6,221 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.94 per share. | 19 Jan 2021 | 2,500 | 59,739 (0%) | 0% | 17.9 | 44,852 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 2,500 | 2,488 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 19 Jan 2021 | 2,500 | 62,239 (0%) | 0% | 2.5 | 6,251 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 62,500 | 62,500 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 31,250 | 59,739 (0%) | 0% | 0 | Common Stock | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.18 per share. | 10 Jan 2021 | 4,080 | 28,489 (0%) | 0% | 18.2 | 74,174 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 17 Dec 2020 | 2,500 | 35,069 (0%) | 0% | 2.5 | 6,251 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2020 | 2,500 | 4,988 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.51 per share. | 17 Dec 2020 | 2,500 | 32,569 (0%) | 0% | 17.5 | 43,780 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.42 per share. | 07 Dec 2020 | 8,791 | 32,569 (0%) | 0% | 18.4 | 161,896 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 5,791 | 0 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.70 per share. | 07 Dec 2020 | 5,791 | 41,360 (0%) | 0% | 12.7 | 73,546 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.37 per share. | 07 Dec 2020 | 3,000 | 35,569 (0%) | 0% | 12.4 | 37,110 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 3,000 | 123,000 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.67 per share. | 03 Dec 2020 | 49,756 | 32,569 (0%) | 0% | 18.7 | 929,079 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.85 per share. | 03 Dec 2020 | 49,000 | 32,569 (0%) | 0% | 18.9 | 923,694 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.17 per share. | 03 Dec 2020 | 36,736 | 69,305 (0%) | 0% | 17.2 | 630,757 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2020 | 36,736 | 0 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.75 per share. | 03 Dec 2020 | 32,291 | 64,860 (0%) | 0% | 16.7 | 540,874 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2020 | 32,291 | 17,709 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.70 per share. | 03 Dec 2020 | 16,709 | 81,569 (0%) | 0% | 12.7 | 212,204 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2020 | 16,709 | 5,791 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.73 per share. | 03 Dec 2020 | 13,020 | 82,325 (0%) | 0% | 17.7 | 230,845 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2020 | 13,020 | 49,480 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.68 per share. | 17 Nov 2020 | 12,420 | 36,136 (0%) | 0% | 17.7 | 219,619 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2020 | 4,283 | 22,500 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 17 Nov 2020 | 4,283 | 32,569 (0%) | 0% | 18 | 77,094 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.70 per share. | 17 Nov 2020 | 4,283 | 36,852 (0%) | 0% | 12.7 | 54,394 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.68 per share. | 17 Nov 2020 | 3,567 | 32,569 (0%) | 0% | 17.7 | 63,054 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2020 | 2,500 | 7,488 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 17 Nov 2020 | 2,500 | 48,556 (0%) | 0% | 17.5 | 43,744 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 17 Nov 2020 | 2,500 | 51,056 (0%) | 0% | 2.5 | 6,251 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.89 per share. | 19 Oct 2020 | 3,217 | 48,556 (0%) | 0% | 17.9 | 57,556 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2020 | 2,500 | 9,988 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 19 Oct 2020 | 2,500 | 51,056 (0%) | 0% | 2.5 | 6,251 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2020 | 717 | 26,783 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.70 per share. | 19 Oct 2020 | 717 | 51,773 (0%) | 0% | 12.7 | 9,106 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.84 per share. | 17 Sep 2020 | 5,000 | 48,556 (0%) | 0% | 18.8 | 94,216 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.70 per share. | 17 Sep 2020 | 2,500 | 53,556 (0%) | 0% | 12.7 | 31,750 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2020 | 2,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2020 | 2,500 | 12,488 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 17 Sep 2020 | 2,500 | 51,056 (0%) | 0% | 2.5 | 6,251 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.37 per share. | 17 Aug 2020 | 5,000 | 48,556 (0%) | 0% | 19.4 | 96,851 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 17 Aug 2020 | 2,500 | 51,056 (0%) | 0% | 2.5 | 6,251 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 2,500 | 30,000 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 2,500 | 14,988 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.70 per share. | 17 Aug 2020 | 2,500 | 53,556 (0%) | 0% | 12.7 | 31,750 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.25 per share. | 17 Jul 2020 | 15,000 | 48,556 (0%) | 0% | 18.2 | 273,687 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.70 per share. | 17 Jul 2020 | 12,500 | 63,556 (0%) | 0% | 12.7 | 158,750 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2020 | 12,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2020 | 2,500 | 17,488 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 17 Jul 2020 | 2,500 | 51,056 (0%) | 0% | 2.5 | 6,251 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2020 | 2,500 | 19,988 | - | - | Stock Option (Right to Buy) | |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.22 per share. | 17 Jun 2020 | 2,500 | 48,556 (0%) | 0% | 17.2 | 43,050 | Common Stock |
Coherus Biosciences Inc | Vincent R. Anicetti | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 17 Jun 2020 | 2,500 | 51,056 (0%) | 0% | 2.5 | 6,251 | Common Stock |